The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC, a for-profit limited liability company, to provide abiraterone tablets. This 1-year base contract with four 1-year option periods has a potential value of $70,208,375.13. The contract will supply the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) with an uninterrupted source of abiraterone acetate 250mg tablets, with an estimated annual requirement of over 39,000 bottles. The awardee will distribute the pharmaceuticals through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. This unrestricted procurement, with a NAICS code of 325412, aims to efficiently acquire the required medications to support patient healthcare needs across federal health facilities nationwide.
The original solicitation, 36E79719R0021, was posted on FedBizOpps with no set-aside provisions. Interested offerors were required to specify the exact product name and National Drug Code, and demonstrate the ability to provide an uninterrupted supply. The place of performance will be the pharmaceutical prime vendor networks serving the VA, DoD, BOP, and IHS. This contract award to Avkare, LLC, a proven supplier of pharmaceuticals and medical equipment to federal agencies, will help ensure consistent access to this critical oncology medication for eligible patients within the government healthcare systems.
Generated 4/16/24, 4:32 PM